Product image of Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s (Emtricitabine, Tenofovir Disoproxil Succinate) supplied by GNH India

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s

Active Ingredient:
Emtricitabine, Tenofovir Disoproxil Succinate
Origin:
EU

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s (Emtricitabine, Tenofovir Disoproxil Succinate)

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s is a combination medication used for HIV treatment. This oral medication helps manage HIV infection by reducing viral load and improving immune function.

Manufacturer / TM Owner

Dr. Reddy's Laboratories (Uk) Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s is primarily used in the treatment of HIV-1 infection. This combination therapy works by inhibiting the reverse transcriptase enzyme, which is essential for the virus to replicate. It is often prescribed as part of a comprehensive antiretroviral therapy regimen to control HIV and prevent its progression. The medication is designed to reduce the amount of HIV in the body, helping to improve immune function and overall health.

Side Effects

  • Common effects of Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s may include nausea, diarrhea, and headache. Some individuals might experience dizziness, fatigue, or rash. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

  • Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients with kidney problems should use this medication with caution, as it can affect renal function. Regular monitoring of kidney function is recommended during treatment.

Avoid Interactions

  • Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s may interact with other medications, including those that affect kidney function or are metabolized by the liver. Alcohol consumption should be avoided, as it can exacerbate side effects. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s is used for the treatment of HIV-1 infection as part of a combination antiretroviral therapy regimen.

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s is taken orally, typically once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, headache, dizziness, fatigue, and rash. These effects are usually mild and temporary.

Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s may interact with other medications, especially those affecting kidney function or metabolized by the liver. Consult your healthcare provider before combining with other drugs.

Patients with kidney problems should use Emtricitabine/Tenofovir Disoproxil Dr. Reddy’s with caution and under medical supervision, as it can affect renal function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Emtricitabine, Tenofovir Disoproxil Succinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT